UK Companies House feature
TEVA LABORATORIES UK LIMITED
Profile
- Company number
- 00532832
- Status
- Active
- Incorporation
- 1954-05-03
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe that preparing the financial statements on a going concern basis is appropriate due to the continued financial support of Teva Pharmaceuticals Europe B.V., a fellow group company. The directors have received confirmation from Teva Pharmaceuticals Europe B.V. that it has pledged its continuing support for a minimum of 12 months from the date of signing these financial statements.”
Significant events
- “During September 2024, the company completed the divestment of several intangible assets as part of a global strategic review by the Teva group to enhance its focus on core products.”
- “On 19 November 2024, the company paid a dividend of £94,000,000 to Teva Pharma Holdings Limited.”
- “The divestments made during 2023 and 2024 may lead to reduced revenues in 2025 and future years.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHARLESWORTH, Stephen Michael | Director | 2020-04-29 | Feb 1967 | British |
| INNES, Kim | Director | 2016-10-01 | Aug 1968 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LIVINGSTONE, Andrew John Robertson | Secretary | 1998-04-01 | 2015-06-01 |
| MORE, William Jamieson | Secretary | — | 1998-03-31 |
| NELLIGAN, Tom | Secretary | 2015-06-01 | 2016-08-02 |
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2017-03-13 | 2017-03-13 |
| BURKE, Diarmuid | Director | 1997-12-01 | 2015-03-30 |
| COOPER, Dean Michael | Director | 2018-07-12 | 2020-04-29 |
| DANIELL, Richard Gordon | Director | 2016-08-02 | 2016-10-01 |
| GOLDBERG, Anthony | Director | — | 1995-06-07 |
| HART, Richard William | Director | — | 1997-11-30 |
| JAKES, Nadine | Director | 2014-12-01 | 2016-08-02 |
| MCDONALD, Michael | Director | 2014-04-02 | 2015-03-30 |
| MORE, William Jamieson | Director | — | 1998-03-31 |
| SOLOMON, Howard | Director | — | 2014-03-31 |
| STAFFORD, Raymond Thomas | Director | — | 2014-04-02 |
| VINCENT, Sara Jayne | Director | 2014-12-01 | 2016-08-02 |
| WILLIAMS, Robert | Director | 2016-08-02 | 2018-06-27 |
| WORTH, John Christopher | Director | 1997-12-01 | 2006-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Teva Pharma Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-08-02 | Active |
Filing timeline
Last 20 of 140 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-17 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-10-06 | AA | accounts | accounts with accounts type full |
| 2024-12-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-10-09 | AA | accounts | accounts with accounts type full |
| 2023-12-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-07 | AA | accounts | accounts with accounts type full |
| 2023-01-03 | AA | accounts | accounts with accounts type full |
| 2022-12-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-01-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-03 | AA | accounts | accounts with accounts type full |
| 2020-12-24 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-11-09 | AA | accounts | accounts with accounts type group |
| 2020-04-29 | TM01 | officers | termination director company with name termination date |
| 2020-04-29 | AP01 | officers | appoint person director company with name date |
| 2019-12-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-10-10 | AA | accounts | accounts with accounts type group |
| 2019-09-30 | CH01 | officers | change person director company with change date |
| 2018-12-12 | CS01 | confirmation-statement | confirmation statement with updates |
| 2018-10-30 | AA | accounts | accounts with accounts type group |
| 2018-07-24 | AD01 | address | change registered office address company with date old address new address |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory